Capricor Therapeutics Inc (CAPR): Capricor Therapeutics (NASDAQ: CAPR), a...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	86
Posts	12203
Boards Moderated	2
Alias Born	12/08/2009

ed3/6me

Re: None

Tuesday, 03/11/2025 10:24:35 PM

Tuesday, March 11, 2025 10:24:35 PM

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the fourth quarter and full year ended December 31, 2024, after the market close on Wednesday, March 19, 2025. Management will then host a webcast and conference call at 4:30 p.m. ET on March 19.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CAPR News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2026 01:55:07 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2026 01:52:26 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:15:07 PM
Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 05/19/2026 06:41:17 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 03:40:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:00:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 09:20:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:06:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:40:53 PM
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 • GlobeNewswire Inc. • 05/04/2026 08:05:00 PM
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting • GlobeNewswire Inc. • 04/22/2026 01:00:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:31:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:07 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 08:24:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:15 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:11 AM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/31/2026 09:24:08 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:23:33 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:23:03 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:22:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 11:15:05 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 09:00:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:01:07 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent CAPR News

More CAPR News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent CAPR News

Go Ad-Free